ライフサイエンスコーパス: travelers' diarrhea

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 received an antibiotic for self-treatment of travelers' diarrhea.

2 as the treatment of choice for uncomplicated travelers' diarrhea.

3 imin provided 72% and 77% protection against travelers' diarrhea and antibiotic-treated travelers' di

4 appears promising as a chemoprophylaxis for travelers' diarrhea and as a treatment of portal systemi

5 Rifaximin is effective for the treatment of travelers' diarrhea and can be considered as the treatme

6 uals susceptible to Escherichia coli-induced travelers' diarrhea and in tear fluid derived from viral

7 t commonly isolated pathogen responsible for travelers' diarrhea and the cause of up to 650 million c

8 NoVs were identified in 10.2% of cases of travelers' diarrhea and, overall, was the second most co

9 ed in the United States for the treatment of travelers' diarrhea caused by noninvasive diarrheagenic

10 Travelers' diarrhea causes substantial morbidity and pos

11 Travelers' diarrhea developed in 14.74% of participants

12 Large field studies of travelers' diarrhea for multiple destinations are limite

13 i (ETEC) is a leading cause of childhood and travelers' diarrhea, for which an effective vaccine is n

14 is responsible for causing severe infant and travelers' diarrhea, gastroenteritis and hemolytic uremi

15 agent, was demonstrated in the treatment of travelers diarrhea in Mexico.

16 Rifaximin safely prevented travelers' diarrhea in Mexico, where most cases are caus

17 NoVs are important pathogens of travelers' diarrhea in multiple regions of the world.

18 tile diarrhea in the developing world and of travelers' diarrhea in visitors to these areas from indu

19 Recommended treatment for travelers' diarrhea includes the combination of an antib

20 When invasive travelers' diarrhea pathogens are suspected, an alternat

21 t travelers' diarrhea and antibiotic-treated travelers' diarrhea, respectively (P < 0.001 for both),

22 In the groups that did not report travelers' diarrhea, rifaximin significantly reduced the

23 Geographic region, occurrence of travelers' diarrhea (TD), age, and use of antimicrobial

24 onducted for the treatment and prevention of travelers' diarrhea, the treatment of portal systemic en

25 enterotoxigenic Escherichia coli (ETEC) and travelers' diarrhea was examined in a high-risk area in

26 Rifaximin prevents travelers' diarrhea with minimal changes in fecal flora,

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。